<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Titrated oral misoprostol for augmenting labour to improve maternal and neonatal outcomes - Vogel, JP - 2013 | Cochrane Library</title> <meta content="Titrated oral misoprostol for augmenting labour to improve maternal and neonatal outcomes - Vogel, JP - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010648.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Titrated oral misoprostol for augmenting labour to improve maternal and neonatal outcomes - Vogel, JP - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010648.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010648.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Titrated oral misoprostol for augmenting labour to improve maternal and neonatal outcomes" name="citation_title"/> <meta content="Joshua P Vogel" name="citation_author"/> <meta content="vogeljo@who.int" name="citation_author_email"/> <meta content="Helen M West" name="citation_author"/> <meta content="The University of Liverpool" name="citation_author_institution"/> <meta content="Therese Dowswell" name="citation_author"/> <meta content="The University of Liverpool" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD010648.pub2" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/09/23" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010648.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010648.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010648.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Administration, Oral; Cervical Ripening [*drug effects, physiology]; Delivery, Obstetric [statistics &amp; numerical data]; Injections, Intravenous; Misoprostol [*administration &amp; dosage, adverse effects]; Oxytocics [*administration &amp; dosage, adverse effects]; Oxytocin [administration &amp; dosage, adverse effects]; Pregnancy Outcome; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010648.pub2&amp;doi=10.1002/14651858.CD010648.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010648.pub2&amp;doi=10.1002/14651858.CD010648.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010648.pub2&amp;doi=10.1002/14651858.CD010648.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010648.pub2&amp;doi=10.1002/14651858.CD010648.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010648.pub2&amp;doi=10.1002/14651858.CD010648.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010648.pub2&amp;doi=10.1002/14651858.CD010648.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010648.pub2&amp;doi=10.1002/14651858.CD010648.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010648.pub2&amp;doi=10.1002/14651858.CD010648.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010648.pub2&amp;doi=10.1002/14651858.CD010648.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010648.pub2&amp;doi=10.1002/14651858.CD010648.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010648.pub2&amp;doi=10.1002/14651858.CD010648.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010648.pub2&amp;doi=10.1002/14651858.CD010648.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010648.pub2&amp;doi=10.1002/14651858.CD010648.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010648.pub2&amp;doi=10.1002/14651858.CD010648.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010648.pub2&amp;doi=10.1002/14651858.CD010648.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010648.pub2&amp;doi=10.1002/14651858.CD010648.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010648.pub2&amp;doi=10.1002/14651858.CD010648.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010648.pub2&amp;doi=10.1002/14651858.CD010648.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010648.pub2&amp;doi=10.1002/14651858.CD010648.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010648.pub2&amp;doi=10.1002/14651858.CD010648.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010648.pub2&amp;doi=10.1002/14651858.CD010648.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010648.pub2&amp;doi=10.1002/14651858.CD010648.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010648.pub2&amp;doi=10.1002/14651858.CD010648.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="QO4KtYGW";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010648\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010648\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010648\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010648\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","fr","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010648.pub2",title:"Titrated oral misoprostol for augmenting labour to improve maternal and neonatal outcomes",firstPublishedDate:"Sep 23, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=QO4KtYGW&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010648.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010648.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010648.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010648.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010648.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010648.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010648.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010648.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010648.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010648.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3200 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010648.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010648.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010648.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010648.pub2/full#CD010648-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010648.pub2/full#CD010648-sec-0114"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010648.pub2/full#CD010648-sec-0022"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010648.pub2/full#CD010648-sec-0026"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010648.pub2/full#CD010648-sec-0027"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010648.pub2/full#CD010648-sec-0065"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010648.pub2/full#CD010648-sec-0108"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/table_n/CD010648StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/table_n/CD010648StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010648.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010648.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010648.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010648.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010648.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010648.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2013 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Titrated oral misoprostol for augmenting labour to improve maternal and neonatal outcomes</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010648.pub2/information#CD010648-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Joshua P Vogel</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010648.pub2/information#CD010648-cr-0003">Helen M West</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010648.pub2/information#CD010648-cr-0004">Therese Dowswell</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/information/en#CD010648-sec-0120">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 23 September 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010648.pub2">https://doi.org/10.1002/14651858.CD010648.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010648-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010648-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010648-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010648-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010648-abs-0007">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010648-abs-0001" lang="en"> <section id="CD010648-sec-0001"> <h3 class="title" id="CD010648-sec-0001">Background</h3> <p>Labour dystocia is associated with a number of adverse maternal and neonatal outcomes. Augmentation of labour is a commonly used intervention in cases of labour dystocia. Misoprostol is an inexpensive and stable prostaglandin E1 analogue that can be administered orally, vaginally, sublingually or rectally. Misoprostol has proven to be effective at stimulating uterine contractions although it can have serious, and even life‐threatening side‐effects. Titration refers to the process of adjusting the dose, frequency, or both, of a medication on the basis of frequent review to achieve optimal outcomes. Studies have reported on a range of misoprostol titration regimens used for labour induction and titrated misoprostol may potentially be effective and safe for augmentation of labour. </p> </section> <section id="CD010648-sec-0002"> <h3 class="title" id="CD010648-sec-0002">Objectives</h3> <p>To examine the effects and safety of titrated oral misoprostol compared with placebo, oxytocin, other interventions, or no active treatment, in women with labour dystocia. </p> </section> <section id="CD010648-sec-0003"> <h3 class="title" id="CD010648-sec-0003">Search methods</h3> <p>The Trials Search Co‐ordinator of the Cochrane Pregnancy and Childbirth Group searched the Cochrane Pregnancy and Childbirth Group’s Trials Register; date of search: 29 May 2013. We also searched the reference lists of retrieved studies </p> </section> <section id="CD010648-sec-0004"> <h3 class="title" id="CD010648-sec-0004">Selection criteria</h3> <p>Randomised trials (including quasi‐randomised and cluster‐randomised trials) comparing titrated oral misoprostol with placebo, other interventions (e.g. oxytocin, other prostaglandins), or no treatment in women requiring augmentation of labour were eligible for inclusion. </p> </section> <section id="CD010648-sec-0005"> <h3 class="title" id="CD010648-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed eligibility for inclusion, carried out data extraction and assessed risk of bias in included studies. Data were entered by one author and checked for accuracy. </p> </section> <section id="CD010648-sec-0006"> <h3 class="title" id="CD010648-sec-0006">Main results</h3> <p>We included two randomised trials with a total of 581 women each comparing different regimens of titrated oral misoprostol with intravenous oxytocin. One study compared 20 mcg doses of misoprostol dissolved in water (repeated every hour up to four hours, after which the dose was increased to 40 mcg per hour up to a maximum total dose of 1600 mcg), while the second study gave women 75 mcg doses (repeated after four hours provided there were no adverse effects observed). </p> <p>Neither trial reported maternal death, severe maternal morbidity, or fetal/neonatal mortality outcomes, and only a few fetal/neonatal morbidity outcomes were considered, none of which were significantly different between groups. For several outcomes (such as maternal side‐effects, instrumental birth, maternal blood transfusion for hypovolaemia and epidural analgesia), the number of events was generally too low for sufficient statistical power to be achieved. Maternal satisfaction was not reported in either trial. One trial reported a slight reduction in the median duration of labour from the start of augmentation to vaginal delivery in the oxytocin group. </p> <p>Neither trial reported significantly higher rates of caesarean section (CS) in the oral misoprostol group. Rates of vaginal delivery within 12 and 24 hours of commencing augmentation were not significantly different in the trial using a 20 mcg misoprostol dose. Neither trial had significantly higher rates of uterine hyperstimulation with fetal heart rate changes in the titrated oral misoprostol group. However, the rates of this outcome varied so greatly between the two studies as to suggest that other factors were at play. The only significant differences between groups related to uterine hyperstimulation (without fetal heart rate changes), and results were not consistent in the two trials. In the trial examining the higher dose of misoprostol, more women in the misoprostol group experienced hyperstimulation of labour measured over a 10‐minute period compared with those receiving oxytocin (risk ratio (RR) 1.17, 95% confidence interval (CI) 1.02 to 1.35, 350 women). In the study examining the lower titrated dose of misoprostol, there was a lower incidence of tachysystole when labour was augmented with titrated oral misoprostol than with oxytocin (RR 0.39, 95% CI 0.17 to 0.91, 231 women) with no occurrences of hypertonus in either group of women. </p> </section> <section id="CD010648-sec-0007"> <h3 class="title" id="CD010648-sec-0007">Authors' conclusions</h3> <p>Important uncertainties still exist on the safety and acceptability of titrated oral misoprostol compared with intravenous oxytocin regimens in women with dystocia following spontaneous onset of labour. Although in facilities where electronic oxytocin infusion is not available, low‐dose titrated misoprostol may offer a better alternative to an uncontrolled oxytocin infusion to avoid hyperstimulation. Further research is needed in both high‐ and low‐resource settings More trials should be conducted to evaluate the effect of a standard titration oral misoprostol regimen, both following spontaneous labour and labour induction. Comparisons with other augmentation methods are also warranted, as are any effects on women's birth experiences. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010648-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010648-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010648-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010648-abs-0005">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010648-abs-0008">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010648-abs-0004" lang="en"> <h3>Adjusted doses of oral misoprostol for treating slow progress in labour</h3> <p>Abnormally slow progress in labour (labour dystocia) may lead to serious complications including death for women and their babies. Drugs to increase the frequency and strength of contractions have often been used in such births. Misoprostol is an inexpensive and stable drug that stimulates uterine contractions, but it can have serious and even life‐threatening side‐effects and so the dose has to be carefully adjusted. Titration refers to the process of adjusting the dosing of a medication on the basis of frequent monitoring to achieve the best outcomes. Titrated misoprostol could be effective in treating delayed progress in labour and as an alternative to oxytocin which is harder to store and is given intravenously by infusion. </p> <p>We identified two randomised controlled trials with 581 women requiring augmentation, each looking at different doses of oral misoprostol compared with oxytocin. One study gave 20 mcg doses of misoprostol every hour up to four hours, after which the dose was increased; the second gave women 75 mcg doses, repeated after four hours provided there were no adverse effects observed. Neither trial reported on the important safety outcomes of maternal or neonatal deaths, or severe maternal ill health. </p> <p>One trial measured duration of labour from the start of augmentation, which was slightly shorter with intravenous oxytocin (5.20 hours compared with 5.22 hours). The number of vaginal deliveries within 12 and 24 hours, and caesarean section rates were similar. Neither trial reported clearly higher rates of uterine hyperstimulation with worrying fetal heart rate changes in the titrated oral misoprostol group. The rates of this outcome in the two studies varied greatly however. The evidence on uterine hyperstimulation without fetal heart rate changes was not consistent. </p> <p>The number of women reporting nausea, vomiting, shivering and pyrexia was low with both misoprostol and oxytocin. Maternal satisfaction was not reported in either trial. </p> <p>Important uncertainties still exist on the safety and acceptability of titrated oral misoprostol for labour dystocia, and further research is needed before it can be recommended as an alternative to oxytocin. However, in facilities that do not have access to electronic oxytocin infusion, lower doses of titrated misoprostol may be a better alternative to avoid hyperstimulation. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010648-sec-0114" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010648-sec-0114"></div> <h3 class="title" id="CD010648-sec-0115">Implications for practice</h3> <section id="CD010648-sec-0115"> <p>Important uncertainties still exist on the safety and acceptability of titrated oral misoprostol compared to IV oxytocin regimens in women with dystocia following spontaneous onset of labour. In addition, there is no consistent definition of a titrated oral misoprostol regimen, thus complicating interpretation. The available evidence suggests titrated oral misoprostol for women with labour dystocia (following spontaneous onset of labour) is not significantly different to IV oxytocin in terms of vaginal delivery within 12 or 24 hours or rates of CS. The evidence on uterine hyperstimulation is not clear; compared with oxytocin (via electronic pump infusion), hyperstimulation may be increased with higher doses of misoprostol, whereas with lower doses it may be reduced. To avoid hyperstimulation, lower doses of misoprostol may be a good alternative in facilities where an uncontrolled oxytocin infusion is the only other option. In addition, clinically important outcomes, such as severe maternal and fetal/newborn morbidity and mortality, as well as maternal adverse effects and acceptability, have not been explored. </p> </section> <h3 class="title" id="CD010648-sec-0116">Implications for research</h3> <section id="CD010648-sec-0116"> <p>Further research is needed before titrated oral misoprostol regimens can be considered a safe, effective and acceptable alternative to oxytocin regimens for augmentation in labour dystocia. More trials should be conducted to evaluate the effect of a standard titration oral misoprostol regimen, both following spontaneous labour and labour induction. Comparisons with other augmentation methods are also warranted, as are any effects on women's birth experiences. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010648-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010648-sec-0022"></div> <section id="CD010648-sec-0023"> <h3 class="title" id="CD010648-sec-0023">Description of the condition</h3> <p>Labour dystocia (or difficult labour) is characterised by abnormally slow progress of labour. It can be due to one or more causes, including abnormalities of uterine contractility or the maternal bony pelvis and soft tissues, as well as abnormal fetal presentation, position or development (<a href="./references#CD010648-bbs2-0034" title="NeilsonJP , LavenderT , QuenbyS , WrayS . Obstructed labour. British Medical Bulletin2003;67:191‐204. ">Neilson 2003</a>). A slow labour does not necessitate a diagnosis of labour dystocia. </p> <p>Labour dystocia is associated with a number of adverse maternal and neonatal outcomes. It can result in a traumatic birth experience (<a href="./references#CD010648-bbs2-0036" title="NystedtA , HögbergU , LundmanB . The negative birth experience of prolonged labour: a case–referent study. Journal of Clinical Nursing2005;14(5):579‐86. ">Nystedt 2005</a>), and may lead to fetal distress requiring operative birth, either by emergency caesarean section (CS) or vaginal instrumental birth (<a href="./references#CD010648-bbs2-0034" title="NeilsonJP , LavenderT , QuenbyS , WrayS . Obstructed labour. British Medical Bulletin2003;67:191‐204. ">Neilson 2003</a>; <a href="./references#CD010648-bbs2-0041" title="SelinL , WallinG , BergM . Dystocia in labour ‐ risk factors, management and outcome: a retrospective observational study in a Swedish setting. Acta Obstetricia et Gynecologica Scandinavica2008;87(2):216‐21. ">Selin 2008</a>). It may result in perinatal or maternal morbidity or mortality (<a href="./references#CD010648-bbs2-0024" title="KjaergaardH , OlsenJ , OttesenB , DykesAK . Incidence and outcomes of dystocia in the active phase of labor in term nulliparous women with spontaneous labor onset. Acta Obstetricia et Gynecologica Scandinavica2009;88(4):402‐7. ">Kjaergaard 2009</a>), especially in settings where emergency CS is not widely available (<a href="./references#CD010648-bbs2-0009" title="BuchmannEJ , PattinsonRC . Babies who die from labour‐related intrapartum hypoxia: a confidential enquiry in South African public hospitals. Tropical Doctor2006;36(1):8‐10. ">Buchmann 2006</a>; <a href="./references#CD010648-bbs2-0032" title="McClureEM , Nalubamba‐PhiriM , GoldenbergRL . Stillbirth in developing countries. International Journal of Gynecology and Obstetrics2006;94(2):82‐90. ">McClure 2006</a>). There is no universally accepted definition of labour dystocia and criteria often vary between studies; however, studies in high‐resource countries report a high incidence of births complicated by dystocia (e.g. 37% in a sample of 2810 healthy, term nulliparas with no indication for induction or elective CS (<a href="./references#CD010648-bbs2-0023" title="KjaergaardH , OlsenJ , OttesenB , NybergP , DykesAK . Obstetric risk indicators for labour dystocia in nulliparous women: a multi‐centre cohort study. BMC Pregnancy and Childbirth2008;8:45. ">Kjaergaard 2008</a>), and 21% in a sample of 1480 deliveries (<a href="./references#CD010648-bbs2-0041" title="SelinL , WallinG , BergM . Dystocia in labour ‐ risk factors, management and outcome: a retrospective observational study in a Swedish setting. Acta Obstetricia et Gynecologica Scandinavica2008;87(2):216‐21. ">Selin 2008</a>)). </p> <p>Of the 3.2 million stillbirths that occur annually, 32% (1.02 million) are intrapartum (occur during labour or delivery) (<a href="./references#CD010648-bbs2-0056" title="YakoobMY , LawnJE , DarmstadtGL , BhuttaZA . Stillbirths: epidemiology, evidence, and priorities for action. Seminars in Perinatology2010;34(6):387‐94. ">Yakoob 2010</a>), and intrapartum complications, such as malpresentation or obstructed labour, are by far the most predictive factors for perinatal mortality, and may increase the risk for perinatal death by up to a factor of 85 in low‐ and middle‐ income countries (<a href="./references#CD010648-bbs2-0027" title="LawnJE , LeeAC , KinneyM , SibleyL , CarloWA , PaulVK , et al. Two million intrapartum‐related stillbirths and neonatal deaths: where, why, and what can be done?. International Journal of Gynecology and Obstetrics2009;107 Suppl 1:S5‐18, S19. ">Lawn 2009</a>). <a href="./references#CD010648-bbs2-0032" title="McClureEM , Nalubamba‐PhiriM , GoldenbergRL . Stillbirth in developing countries. International Journal of Gynecology and Obstetrics2006;94(2):82‐90. ">McClure 2006</a> et al reported that in six countries with low availability of CS, the most important cause of stillbirth was obstructed or prolonged labour with associated asphyxia, infection and birth injury. </p> <p>Inadequate uterine contractions, fetal malposition, or cephalopelvic disproportion (baby's head/body too large to fit through pelvis) may cause labour dystocia (<a href="./references#CD010648-bbs2-0044" title="Shields SG Ratcliffe SD FontaineP Leeman L . Dystocia in nulliparous Women. American Family Physician2007;75(11):1671‐8. ">Shields 2007</a>). Nulliparous women have slower labour progression than multiparous women (<a href="./references#CD010648-bbs2-0052" title="VahratianA , HoffmanMK , TroendleJF , ZhangJ . The impact of parity on course of labor in a contemporary population. Birth2006;33(1):12‐7. ">Vahratian 2006</a>), and those who are overweight experience a slower first and second stage of labour compared with women of normal weight (<a href="./references#CD010648-bbs2-0051" title="VahratianA , ZhangJ , TroendleJF , SavitzDA , Siega‐RizAM . Maternal prepregnancy overweight and obesity and the pattern of labor progression in term nulliparous women. Obstetrics &amp; Gynecology2004;104(5 Pt 1):943‐51. ">Vahratian 2004</a>). Other factors associated with increased risk of prolonged labour include advanced maternal age (<a href="./references#CD010648-bbs2-0022" title="KalogiannidisI , Margioula‐SiarkouC , PetousisS , MasouraS , GoutzioulisA , TraianosA , et al. Parity affects pregnancy outcomes in women 35 and older. Clinical &amp; Experimental Obstetrics &amp; Gynecology2011;38(2):146‐9. ">Kalogiannidis 2011</a>; <a href="./references#CD010648-bbs2-0042" title="SheinerE , LevyA , FeinsteinU , HallakM , MazorM . Risk factors and outcome of failure to progress during the first stage of labor: a population‐based study. Acta Obstetricia et Gynecologica Scandinavica2002;81(3):222‐6. ">Sheiner 2002</a>), especially older primagravidas (<a href="./references#CD010648-bbs2-0022" title="KalogiannidisI , Margioula‐SiarkouC , PetousisS , MasouraS , GoutzioulisA , TraianosA , et al. Parity affects pregnancy outcomes in women 35 and older. Clinical &amp; Experimental Obstetrics &amp; Gynecology2011;38(2):146‐9. ">Kalogiannidis 2011</a>); multiparity with no previous vaginal birth; gestational age over 42 weeks (<a href="./references#CD010648-bbs2-0041" title="SelinL , WallinG , BergM . Dystocia in labour ‐ risk factors, management and outcome: a retrospective observational study in a Swedish setting. Acta Obstetricia et Gynecologica Scandinavica2008;87(2):216‐21. ">Selin 2008</a>); obesity (<a href="./references#CD010648-bbs2-0051" title="VahratianA , ZhangJ , TroendleJF , SavitzDA , Siega‐RizAM . Maternal prepregnancy overweight and obesity and the pattern of labor progression in term nulliparous women. Obstetrics &amp; Gynecology2004;104(5 Pt 1):943‐51. ">Vahratian 2004</a>); epidural analgesia (<a href="./references#CD010648-bbs2-0023" title="KjaergaardH , OlsenJ , OttesenB , NybergP , DykesAK . Obstetric risk indicators for labour dystocia in nulliparous women: a multi‐centre cohort study. BMC Pregnancy and Childbirth2008;8:45. ">Kjaergaard 2008</a>; <a href="./references#CD010648-bbs2-0037" title="O'HanaH P , LevyA , RozenA , GreembergL , ShapiraY , SheinerE . The effect of epidural analgesia on labor progress and outcome in nulliparous women. Journal of Maternal‐Fetal &amp; Neonatal Medicine2008;21(8):517‐21. ">O'Hana 2008</a>; <a href="./references#CD010648-bbs2-0041" title="SelinL , WallinG , BergM . Dystocia in labour ‐ risk factors, management and outcome: a retrospective observational study in a Swedish setting. Acta Obstetricia et Gynecologica Scandinavica2008;87(2):216‐21. ">Selin 2008</a>; <a href="./references#CD010648-bbs2-0042" title="SheinerE , LevyA , FeinsteinU , HallakM , MazorM . Risk factors and outcome of failure to progress during the first stage of labor: a population‐based study. Acta Obstetricia et Gynecologica Scandinavica2002;81(3):222‐6. ">Sheiner 2002</a>); female circumcision (<a href="./references#CD010648-bbs2-0013" title="ChibberR , El‐SalehE , ElHarmiJ . Female circumcision: obstetrical and psychological sequelae continues unabated in the 21st century. Journal of Maternal‐Fetal &amp; Neonatal Medicine2011;24(6):833‐6. ">Chibber 2011</a>); vitamin D deficiency (<a href="./references#CD010648-bbs2-0040" title="SchollTO , ChenX , SteinP . Maternal vitamin D status and delivery by cesarean. Nutrients2012;4(4):319‐30. ">Scholl 2012</a>); infertility treatment; induction of labour; prelabour rupture of membranes; hypertensive disorders; hydramnios (too much amniotic fluid); gestational diabetes (<a href="./references#CD010648-bbs2-0042" title="SheinerE , LevyA , FeinsteinU , HallakM , MazorM . Risk factors and outcome of failure to progress during the first stage of labor: a population‐based study. Acta Obstetricia et Gynecologica Scandinavica2002;81(3):222‐6. ">Sheiner 2002</a>); early admission to a labour unit (<a href="./references#CD010648-bbs2-0023" title="KjaergaardH , OlsenJ , OttesenB , NybergP , DykesAK . Obstetric risk indicators for labour dystocia in nulliparous women: a multi‐centre cohort study. BMC Pregnancy and Childbirth2008;8:45. ">Kjaergaard 2008</a>); macrosomia (large baby) (<a href="./references#CD010648-bbs2-0021" title="HogbergU , Lekas BergM . Prolonged labour attributed to large fetus. Gynecologic and Obstetric Investigation2000;49(3):160‐4. ">Hogberg 2000</a>; <a href="./references#CD010648-bbs2-0041" title="SelinL , WallinG , BergM . Dystocia in labour ‐ risk factors, management and outcome: a retrospective observational study in a Swedish setting. Acta Obstetricia et Gynecologica Scandinavica2008;87(2):216‐21. ">Selin 2008</a>); occipitoposterior (back‐to‐back) position (<a href="./references#CD010648-bbs2-0044" title="Shields SG Ratcliffe SD FontaineP Leeman L . Dystocia in nulliparous Women. American Family Physician2007;75(11):1671‐8. ">Shields 2007</a>); short maternal stature (<a href="./references#CD010648-bbs2-0038" title="PiperJM , BollingDR , NewtonER . The second stage of labor: factors influencing duration. American Journal of Obstetrics and Gynecology1991;165(4 Pt 1):976‐9. ">Piper 1991</a>; <a href="./references#CD010648-bbs2-0043" title="SheinerE , LevyA , KatzM , MazorM . Short stature ‐ an independent risk factor for Caesarean delivery. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2005;120(2):175‐8. ">Sheiner 2007</a>); and high levels of stress hormones in the mother (<a href="./references#CD010648-bbs2-0028" title="LedermanRP , LedermanE , WorkBAJr , McCannDS . The relationship of maternal anxiety, plasma catecholamines, and plasma cortisol to progress in labor. American Journal of Obstetrics &amp; Gynecology1978;132(5):495‐500. ">Lederman 1978</a>). </p> </section> <section id="CD010648-sec-0024"> <h3 class="title" id="CD010648-sec-0024">Description of the intervention</h3> <p>Augmentation of labour is a commonly used intervention globally in cases of labour dystocia; <a href="./references#CD010648-bbs2-0029" title="LovoldA , StantonC , ArmbrusterD . How to avoid iatrogenic morbidity and mortality while increasing availability of oxytocin and misoprostol for PPH prevention?. International Journal of Gynecology &amp; Obstetrics2008;103(3):276‐82. ">Lovold 2008</a> identified augmentation rates of 2.5% to 32.9% in provinces of 11 lower‐income countries. In high‐income settings, labour dystocia is generally managed using a titrated intravenous oxytocin regimen via a regulatory infusion pump with continuous fetal monitoring (<a href="./references#CD010648-bbs2-0029" title="LovoldA , StantonC , ArmbrusterD . How to avoid iatrogenic morbidity and mortality while increasing availability of oxytocin and misoprostol for PPH prevention?. International Journal of Gynecology &amp; Obstetrics2008;103(3):276‐82. ">Lovold 2008</a>). However, many facilities in low‐income settings face significant hurdles in the availability of appropriately trained staff, adequate patient supervision, fetal monitoring and the availability and use of clinical practice guidelines (<a href="./references#CD010648-bbs2-0045" title="SimpsonKR , AtterburyJ . Trends and issues in labor induction in the United States: implications for clinical practice. Journal of Obstetric, Gynecologic, and Neonatal Nursing2003;32(6):767‐79. ">Simpson 2003</a>). The quality of oxytocin may be poor (<a href="./references#CD010648-bbs2-0047" title="StantonC , KoskiA , CofieP , MirzabagiE , GradyBL , BrookeS . Uterotonic drug quality: an assessment of the potency of injectable uterotonic drugs purchased by simulated clients in three districts in Ghana. BMJ open2012;2(3):e000431. [DOI: 10.1136/bmjopen‐2011‐000431] ">Stanton 2012</a>), or may be administered without the aid of infusion pumps or fetal monitoring (<a href="./references#CD010648-bbs2-0029" title="LovoldA , StantonC , ArmbrusterD . How to avoid iatrogenic morbidity and mortality while increasing availability of oxytocin and misoprostol for PPH prevention?. International Journal of Gynecology &amp; Obstetrics2008;103(3):276‐82. ">Lovold 2008</a>). Oxytocin misuse increases the risk of ruptured uterus, fetal asphyxia and fetal death (<a href="./references#CD010648-bbs2-0025" title="KonjeJC , OdukoyaOA , LadipoOA . Ruptured uterus in Ibadan—a twelve year review. International Journal of Gynecology and Obstetrics1990;32(4):207‐13. ">Konje 1990</a>; <a href="./references#CD010648-bbs2-0029" title="LovoldA , StantonC , ArmbrusterD . How to avoid iatrogenic morbidity and mortality while increasing availability of oxytocin and misoprostol for PPH prevention?. International Journal of Gynecology &amp; Obstetrics2008;103(3):276‐82. ">Lovold 2008</a>). </p> <p>Misoprostol is an inexpensive and stable prostaglandin E1 analogue that can be administered orally, vaginally, sublingually or rectally (<a href="./references#CD010648-bbs2-0054" title="WeeksAD , FialaC , SafarP . Misoprostol and the debate over off‐label drug use. BJOG: an International Journal of Obstetrics and Gynaecology2005;112(3):269‐72. ">Weeks 2005</a>). It has proven to be effective at stimulating uterine contractions (<a href="./references#CD010648-bbs2-0035" title="NormanJE , ThongKJ , BairdDT . Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone. Lancet1991;338(8777):1233‐6. ">Norman 1991</a>), even at low doses (<a href="./references#CD010648-bbs2-0026" title="KundodyiwaTW , AlfirevicZ , WeeksAD . Low‐dose oral misoprostol for induction of labor: a systematic review. Obstetrics &amp; Gynecology2009;113(2 Pt 1):374‐83. ">Kundodyiwa 2009</a>). As a prostaglandin analogue, misoprostol has ubiquitous effects on many organ systems (<a href="./references#CD010648-bbs2-0019" title="HofmeyrGJ , GülmezogluAM , NovikovaN , LawrieTA . Postpartum misoprostol for preventing maternal mortality and morbidity. Cochrane Database of Systematic Reviews2011, Issue 2. [DOI: 10.1002/14651858.CD008982] ">Hofmeyr 2011</a>). The side‐effects of misoprostol include pyrexia (fever) and shivering, hyperpyrexia (which may be life‐threatening), decrease in heart rate, uterine hyperstimulation and uterine rupture (<a href="./references#CD010648-bbs2-0018" title="HofmeyrGJ , GulmezogluAM , PileggiC . Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2010, Issue 10. [DOI: 10.1002/14651858.CD000941.pub2] ">Hofmeyr 2010</a>; <a href="./references#CD010648-bbs2-0020" title="HofmeyrGJ , GülmezogluAM , NovikovaN , LawrieTA . Postpartum misoprostol for preventing maternal mortality and morbidity. Cochrane Database of Systematic Reviews2013, Issue 7. [DOI: 10.1002/14651858.CD008982.pub2] ">Hofmeyr 2013</a>; <a href="./references#CD010648-bbs2-0048" title="TangOS , Gemzell‐DanielssonK , HoPC . Misoprostol: Pharmacokinetic profiles, effects on the uterus and side‐effects. International Journal of Gynecology &amp; Obstetrics2007;99 Suppl 2:S160‐S167. ">Tang 2007</a>). </p> <p>While originally marketed for the prevention and treatment of gastric ulcers, misoprostol has a wide range of obstetric applications (<a href="./references#CD010648-bbs2-0007" title="BlanchardK , ClarkS , WinikoffB , GainesG , KabaniG , ShannonC . Misoprostol for women's health: a review. Obstetrics &amp; Gynecology2002;99(2):316‐32. ">Blanchard 2002</a>). The low cost, heat stability, ease of administration and storage of misoprostol are advantageous in many low‐resource settings over other oxytocics (<a href="./references#CD010648-bbs2-0007" title="BlanchardK , ClarkS , WinikoffB , GainesG , KabaniG , ShannonC . Misoprostol for women's health: a review. Obstetrics &amp; Gynecology2002;99(2):316‐32. ">Blanchard 2002</a>). The obstetric applications of misoprostol include induction and augmentation of labour, prevention and treatment of postpartum haemorrhage, evacuation of the uterus after pregnancy failure and induced abortion (<a href="./references#CD010648-bbs2-0019" title="HofmeyrGJ , GülmezogluAM , NovikovaN , LawrieTA . Postpartum misoprostol for preventing maternal mortality and morbidity. Cochrane Database of Systematic Reviews2011, Issue 2. [DOI: 10.1002/14651858.CD008982] ">Hofmeyr 2011</a>; <a href="./references#CD010648-bbs2-0055" title="WeeksA , FaundesA . Misoprostol in obstetrics and gynecology. International Journal of Gynecology and Obstetrics2007;99 Suppl 2:S156‐S159. ">Weeks 2007</a>). Despite this, only a small number of countries have licensed misoprostol for obstetric use (<a href="./references#CD010648-bbs2-0054" title="WeeksAD , FialaC , SafarP . Misoprostol and the debate over off‐label drug use. BJOG: an International Journal of Obstetrics and Gynaecology2005;112(3):269‐72. ">Weeks 2005</a>). There is no guidance provided by manufacturers regarding safe and appropriate dosage in obstetric situations (<a href="./references#CD010648-bbs2-0014" title="FriedmanMA . Manufacturer's earning regarding unapproved uses of misoprostol. New England Journal of Medicine2001;344(1):61. ">Friedman 2001</a>). </p> <p>Administered orally or vaginally, misoprostol is effective for the induction of labour (<a href="./references#CD010648-bbs2-0030" title="MarguliesM , Campos PérezG , VotoLS . Misoprostol to induce labour. Lancet1992;339(8784):64. ">Margulies 1992</a>), though it poses certain risks (<a href="./references#CD010648-bbs2-0016" title="HofmeyrG J , GulmezogluA M , AlfirevicZ . Misoprostol for induction of labour: a systematic review. British Journal of Obstetrics and Gynaecology1999;106(8):798‐803. ">Hofmeyr 1999</a>; <a href="./references#CD010648-bbs2-0026" title="KundodyiwaTW , AlfirevicZ , WeeksAD . Low‐dose oral misoprostol for induction of labor: a systematic review. Obstetrics &amp; Gynecology2009;113(2 Pt 1):374‐83. ">Kundodyiwa 2009</a>). A Cochrane review of misoprostol use for cervical ripening and labour induction concluded that it is more effective than conventional methods (<a href="./references#CD010648-bbs2-0018" title="HofmeyrGJ , GulmezogluAM , PileggiC . Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2010, Issue 10. [DOI: 10.1002/14651858.CD000941.pub2] ">Hofmeyr 2010</a>); however, limitations in the evidence mean that the possibility of uncommon serious adverse effects cannot be excluded. Specifically, the studies reviewed were not large enough to conclude whether misoprostol use could cause an unacceptably high number of serious adverse events including uterine rupture and asphyxial fetal deaths. Oral administration of misoprostol has been shown to have similar safety and efficacy to vaginally‐administered misoprostol for induction of labour (<a href="./references#CD010648-bbs2-0005" title="AbbassiRM , SirichandP , RizviS . Safety and efficacy of oral versus vaginal misoprostol use for induction of labour at term. Journal of the College of Physicians &amp; Surgeons ‐ Pakistan: JCPSP2008;18(10):625‐9. ">Abbassi 2008</a>; <a href="./references#CD010648-bbs2-0050" title="UludagS , Salihoglu SaricaliF , MadazliR , CepniI . A comparison of oral and vaginal misoprostol for induction of labor. European Journal of Obstetrics, Gynecology, &amp; Reproductive Biology2005;122(1):57‐60. ">Uludag 2005</a>), but oral misoprostol performed better in terms of treatment interval and number of doses required (<a href="./references#CD010648-bbs2-0005" title="AbbassiRM , SirichandP , RizviS . Safety and efficacy of oral versus vaginal misoprostol use for induction of labour at term. Journal of the College of Physicians &amp; Surgeons ‐ Pakistan: JCPSP2008;18(10):625‐9. ">Abbassi 2008</a>), and is preferred by women (<a href="./references#CD010648-bbs2-0033" title="NassarAH , AwwadJ , KhalilAM , Abu‐MusaA , MehioG , UstaIM . A randomised comparison of patient satisfaction with vaginal and sublingual misoprostol for induction of labour at term. BJOG: an International Journal of Obstetrics &amp; Gynaecology2007;114(10):1215‐21. ">Nassar 2007</a>). </p> <p>Titration refers to the process of adjusting the dose, frequency ‐ or both ‐ of a medication on the basis of frequent review to achieve optimal outcomes. Titration regimens have the advantage of potentially avoiding adverse outcomes, by using smaller doses, and dosing only as required. Titration of oral misoprostol for labour induction using a misoprostol solution was a pioneered by Hofmeyr and colleagues (<a href="./references#CD010648-bbs2-0017" title="HofmeyrGJ , AlfirevicZ , MatonhodzeB , BrocklehurstP , CampbellE , NikodemVC . Titrated oral misoprostol solution for induction of labour: a multi‐centre, randomised trial. BJOG: an International Journal of Obstetrics and Gynaecology2001;109(9):952‐9. ">Hofmeyr 2001a</a>), and several studies have reported on a range of misoprostol titration regimens for labour induction (<a href="./references#CD010648-bbs2-0008" title="BrickerL , PedenH , TomlinsonAJ , Al‐HussainiTK , IdamaT , CandelierC , et al. Titrated low‐dose vaginal and/or oral misoprostol to induce labour for prelabour membrane rupture: a randomised trial. BJOG: an International Journal of Obstetrics &amp; Gynaecology2008;115(12):1503‐11. ">Bricker 2008</a>; <a href="./references#CD010648-bbs2-0010" title="ChengSY , ChenTC . Pilot study of labor induction with titrated oral misoprostol. Taiwanese Journal of Obstetrics &amp; Gynecology2006;45(3):225‐9. ">Cheng 2006</a>; <a href="./references#CD010648-bbs2-0011" title="ChengSY , MingH , LeeJC . Titrated oral compared with vaginal misoprostol for labor induction: a randomized controlled trial. Obstetrics &amp; Gynecology2008;111(1):119‐25. ">Cheng 2008</a>; <a href="./references#CD010648-bbs2-0012" title="ChengSY , HsueCS , HwangGH , ChenW , LiTC . Comparison of labor induction with titrated oral misoprostol solution between nulliparous and multiparous women. Journal of Obstetrics &amp; Gynaecology Research2010;36(1):72‐8. ">Cheng 2010</a>; <a href="./references#CD010648-bbs2-0002" title="HoM , ChengSY , LiTC . Titrated oral misoprostol solution compared with intravenous oxytocin for labor augmentation: a randomized controlled trial. Obstetrics &amp; Gynecology2010;116(3):612‐8. ">Ho 2010</a>; <a href="./references#CD010648-bbs2-0031" title="MatonhodzeB , HofmeyrGJ , LevinJ . Labour induction at term‐‐a randomised trial comparing Foley catheter plus titrated oral misoprostol solution, titrated oral misoprostol solution alone, and dinoprostone. South African Medical Journal. Suid‐Afrikaanse Tydskrif Vir Geneeskunde2003;93(5):375‐9. ">Matonhodze 2003</a>; <a href="./references#CD010648-bbs2-0046" title="SouzaAS , ScavuzziA , RodriguesDC , OliveiraRD , FeitosaFE , AmorimMM . Titrated oral solution of misoprostol for labour induction: a pilot study. Revista Brasileira de Ginecologia e Obstetricia2010;32(5):208‐13. ">Souza 2010</a>; <a href="./references#CD010648-bbs2-0049" title="ThaisomboonA , RussameecharoenK , WanitpongpanP , PhattanachindakunB , ChangnoiA . Comparison of the efficacy and safety of titrated oral misoprostol and a conventional oral regimen for cervical ripening and labor induction. International Journal of Gynecology &amp; Obstetrics2012;116(1):13‐6. ">Thaisomboon 2012</a>; <a href="./references#CD010648-bbs2-0057" title="ZvandasaraP , SaungwemeG , MlamboJ , ChidemboW , MadzivanziraN , MwanjiraC . Induction of labour with titrated oral misoprostol suspension. A comparative study with vaginal misoprostol. Central African Journal of Medicine2008;54(9‐12):43‐9. ">Zvandasara 2008</a>). Given the efficacy of oral misoprostol for augmentation of labour (<a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a>), efforts have been made to identify a safe and effective titration regimen for using misoprostol for this purpose (<a href="./references#CD010648-bbs2-0002" title="HoM , ChengSY , LiTC . Titrated oral misoprostol solution compared with intravenous oxytocin for labor augmentation: a randomized controlled trial. Obstetrics &amp; Gynecology2010;116(3):612‐8. ">Ho 2010</a>; <a href="./references#CD010648-bbs2-0053" title="VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . A dose‐finding study of oral misoprostol for labor augmentation. American Journal of Obstetrics and Gynecology2011;204(6):560.e1‐5. ">Villano 2011</a>). </p> </section> <section id="CD010648-sec-0025"> <h3 class="title" id="CD010648-sec-0025">Why it is important to do this review</h3> <p>There is already evidence about other pharmacological and non‐pharmacological methods of augmenting labour. Methods vary in effectiveness, and some methods may be more appropriate for use in high‐ or low‐resource settings, either because of cost, availability or resources. As an inexpensive drug that does not need refrigeration and can be administered orally, misoprostol may offer an alternative to other commonly‐used augmentation agents. Titration regimens using oral misoprostol have now been examined in trials, so this review fills a gap in the evidence. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010648-sec-0026" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010648-sec-0026"></div> <p>To examine the effects and safety of titrated oral misoprostol compared with placebo, oxytocin, other interventions for augmentation of labour, or no active treatment, in women with dystocia. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010648-sec-0027" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010648-sec-0027"></div> <section id="CD010648-sec-0028"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010648-sec-0029"> <h4 class="title">Types of studies</h4> <p>Randomised trials (including quasi‐randomised trials where allocation is not truly random, for example, alternative allocation). </p> <p>We planned to include trials with either individual‐ or cluster‐randomisation. In this version of the review we did not identify any cluster‐randomised trials. We planned to include studies reported in published abstracts provided that there was sufficient information to assess risk of bias, and results were reported by randomisation group. </p> </section> <section id="CD010648-sec-0030"> <h4 class="title">Types of participants</h4> <p>Women in labour with dystocia requiring labour augmentation (as defined by trialists). We included trials including nulliparous or multiparous women, or both. We did not plan to exclude trials that included women with pregnancy complications recruited as part of broader populations, but we have not included trials focusing specifically on high‐risk groups. </p> </section> <section id="CD010648-sec-0031"> <h4 class="title">Types of interventions</h4> <p>We planned to include trials comparing titrated oral misoprostol with:</p> <p> <ol id="CD010648-list-0001"> <li> <p>placebo;</p> </li> <li> <p>other pharmacological or non‐pharmacological interventions (e.g. oxytocin, other prostaglandins);</p> </li> <li> <p>no treatment.</p> </li> </ol> </p> <p>If data were available, we also planned to compare titrated oral misoprostol with other regimens of misoprostol but no such trials were identified in this version of the review. If, in future updates, we identify trials where titrated misoprostol is used with other interventions (e.g. amniotomy), including induction of labour regimens, we will include the trial, provided women in both the intervention and control arms received the same co‐intervention. </p> </section> <section id="CD010648-sec-0032"> <h4 class="title">Types of outcome measures</h4> <section id="CD010648-sec-0033"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD010648-list-0002"> <li> <p>Maternal death or severe morbidity (e.g. ruptured uterus, admission to intensive care unit, septicaemia, organ failure). </p> </li> <li> <p>Uterine hyperstimulation with fetal heart rate (FHR) changes.</p> </li> <li> <p>Perinatal death (stillbirth and neonatal death).</p> </li> </ol> </p> </section> <section id="CD010648-sec-0034"> <h5 class="title">Secondary outcomes</h5> <section id="CD010648-sec-0035"> <h6 class="title">Maternal</h6> <p> <ol id="CD010648-list-0003"> <li> <p>Maternal mortality.</p> </li> <li> <p>Serious maternal morbidity (e.g. ruptured uterus, admission to intensive care unit, septicaemia, organ failure). </p> </li> <li> <p>Duration of labour.</p> </li> <li> <p>Caesarean section.</p> </li> <li> <p>Caesarean section for fetal distress.</p> </li> <li> <p>Instrumental birth.</p> </li> <li> <p>Caesarean section for prolonged labour.</p> </li> <li> <p>Duration of first stage of labour.</p> </li> <li> <p>Duration of second stage of labour.</p> </li> <li> <p>Postpartum haemorrhage (as defined by trialists).</p> </li> <li> <p>Hyperstimulation of labour.</p> </li> <li> <p>Diagnosis of chorioamnionitis (inflammation of the fetal membranes).</p> </li> <li> <p>Episiotomy.</p> </li> <li> <p>2nd or 3rd degree perineal tear.</p> </li> <li> <p>Breastfeeding.</p> </li> <li> <p>Maternal satisfaction with care in labour.</p> </li> <li> <p>Postnatal depression.</p> </li> <li> <p>Vaginal birth not achieved within 24 hours of onset of labour.</p> </li> </ol> </p> </section> <section id="CD010648-sec-0036"> <h6 class="title">Fetal/neonatal</h6> <p> <ol id="CD010648-list-0004"> <li> <p>Fetal intrapartum death.</p> </li> <li> <p>Early neonatal death.</p> </li> <li> <p>Birth trauma (e.g. Erb's palsy, fractured skull, cephalhaematoma, fractured clavicle).</p> </li> <li> <p>pH of arterial cord blood less than 7.0.</p> </li> <li> <p>Neonatal morbidity, excluding malformations (e.g. seizures, birth asphyxia, neonatal encephalopathy, infection requiring antibiotics). </p> </li> <li> <p>Need for intubation at birth.</p> </li> <li> <p>Childhood disability.</p> </li> <li> <p>Apgar score less than seven at five minutes.</p> </li> <li> <p>Admission to neonatal intensive care unit (NICU).</p> </li> <li> <p>Duration of hospital stay.</p> </li> </ol> </p> </section> </section> </section> </section> <section id="CD010648-sec-0037"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010648-sec-0038"> <h4 class="title">Electronic searches</h4> <p>We asked the Trials Search Co‐ordinator of the Cochrane Pregnancy and Childbirth Group to search the Cochrane Pregnancy and Childbirth Group’s Trials Register. Date of search: 29 May 2013. </p> <p>The Cochrane Pregnancy and Childbirth Group’s Trials Register is maintained by the Trials Search Co‐ordinator and contains trials identified from: </p> <p> <ol id="CD010648-list-0005"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE;</p> </li> <li> <p>weekly searches of Embase;</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals, plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Details of the search strategies for CENTRAL, MEDLINE and Embase, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the ‘Specialized Register’ section within the editorial information about the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html" target="_blank">Cochrane Pregnancy and Childbirth Group</a>. </p> <p>Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co‐ordinator searches the register for each review using the topic list rather than keywords. </p> </section> <section id="CD010648-sec-0039"> <h4 class="title">Searching other resources</h4> <p>In addition, we searched the reference lists of reports identified by the search.</p> <p>We did not apply any language restrictions.</p> </section> </section> <section id="CD010648-sec-0040"> <h3 class="title" id="CD010648-sec-0040">Data collection and analysis</h3> <section id="CD010648-sec-0041"> <h4 class="title">Selection of studies</h4> <p>Two review authors assessed eligibility for inclusion by independently examining all the potential studies we identified as a result of the search strategy. We resolved any disagreement through discussion or, if required, we consulted a third person. </p> <p>We created a study flow diagram to map out the number of records identified, included and excluded. </p> </section> <section id="CD010648-sec-0042"> <h4 class="title">Data extraction and management</h4> <p>We designed a form to extract data. For eligible studies, at least two review authors extracted the data using the agreed form. We resolved discrepancies through discussion or, if required, we consulted a third person. We entered data into Review Manager software (<a href="./references#CD010648-bbs2-0039" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>), and checked for accuracy. </p> <p>If information regarding any of the above was unclear, we planned to contact authors of the original reports to request that they provide further details. </p> </section> <section id="CD010648-sec-0043"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010648-bbs2-0015" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We resolved any disagreement by discussion or by involving a third assessor. </p> <section id="CD010648-sec-0044"> <h5 class="title">(1) Random sequence generation (checking for possible selection bias)</h5> <p>For each included study, we describe the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>We assessed the method as:</p> <p> <ul id="CD010648-list-0006"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD010648-sec-0045"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>For each included study, we describe the method used to conceal allocation to interventions prior to assignment, and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We assessed the methods as:</p> <p> <ul id="CD010648-list-0007"> <li> <p>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD010648-sec-0046"> <h5 class="title">(3.1) Blinding of participants and personnel (checking for possible performance bias)</h5> <p>For each included study, we describe the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding would be unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods as:</p> <p> <ul id="CD010648-list-0008"> <li> <p>low, high or unclear risk of bias for participants;</p> </li> <li> <p>low, high or unclear risk of bias for personnel.</p> </li> </ul> </p> </section> <section id="CD010648-sec-0047"> <h5 class="title">(3.2) Blinding of outcome assessment (checking for possible detection bias)</h5> <p>For each included study, we describe the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed methods used to blind outcome assessment as low, high or unclear risk of bias. </p> </section> <section id="CD010648-sec-0048"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data) </h5> <p>For each included study and each outcome or class of outcomes, we describe the completeness of data including attrition and exclusions from the analysis. We state whether attrition and exclusions were reported, and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or supplied by the trial authors, we planned to re‐include missing data in the analyses. </p> <p>We assessed methods as:</p> <p> <ul id="CD010648-list-0009"> <li> <p>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups); </p> </li> <li> <p>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as treated’ analysis done with substantial departure of intervention received from that assigned at randomisation); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD010648-sec-0049"> <h5 class="title">(5) Selective reporting (checking for reporting bias)</h5> <p>For each included study, we describe how we investigated the possibility of selective outcome reporting bias and what we found. </p> <p>We assessed the methods as:</p> <p> <ul id="CD010648-list-0010"> <li> <p>low risk of bias (where it is clear that all of the study’s pre‐specified outcomes and all expected outcomes of interest to the review have been reported); </p> </li> <li> <p>high risk of bias (where not all the study’s pre‐specified outcomes have been reported; one or more reported primary outcomes were not pre‐specified; outcomes of interest are reported incompletely and so cannot be used; or study failed to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD010648-sec-0050"> <h5 class="title">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</h5> <p>For each included study, we describe any important concerns we have about other possible sources of bias. </p> <p>We assessed whether each study was free of other problems that could put it at risk of bias and assess each as: </p> <p> <ul id="CD010648-list-0011"> <li> <p>low risk of other bias;</p> </li> <li> <p>high risk of other bias;</p> </li> <li> <p>unclear whether there is risk of other bias.</p> </li> </ul> </p> </section> <section id="CD010648-sec-0051"> <h5 class="title">(7) Overall risk of bias</h5> <p>We have made explicit judgements about whether studies are at high risk of bias, according to the criteria given in the <i>Handbook</i> (<a href="./references#CD010648-bbs2-0015" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). With reference to (1) to (6) above, we assessed the likely magnitude and direction of the bias and whether we considered it was likely to impact on the findings. We planned to explore the impact of the level of bias through undertaking sensitivity analyses ‐ <i>see</i><a href="#CD010648-sec-0064">Sensitivity analysis</a>. </p> </section> </section> <section id="CD010648-sec-0052"> <h4 class="title">Measures of treatment effect</h4> <section id="CD010648-sec-0053"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we present results as summary risk ratio with 95% confidence intervals. </p> </section> <section id="CD010648-sec-0054"> <h5 class="title">Continuous data</h5> <p>For continuous data, we present the mean difference with 95% confidence intervals. In this version of the review, we have not pooled any findings from trials but in future updates we will use the mean difference to combine findings from trials provided outcomes are measured in the same way between trials. We will use the standardised mean difference to combine trials that measure the same outcome, but use different methods to do so. </p> </section> </section> <section id="CD010648-sec-0055"> <h4 class="title">Unit of analysis issues</h4> <section id="CD010648-sec-0056"> <h5 class="title">Cluster‐randomised trials</h5> <p>We did not identify any cluster‐randomised trials in this version of the review. In future updates, if such trials are identified, we will include cluster‐randomised trials in the analyses along with individually‐randomised trials. We will adjust their sample sizes using the methods described in the <i>Handbook</i> (<a href="./references#CD010648-bbs2-0015" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>), using an estimate of the intracluster correlation co‐efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population. If we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster‐randomised trials and individually‐randomised trials, we plan to synthesise the relevant information. We will consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely. </p> <p>We will also acknowledge heterogeneity in the randomisation unit and perform a sensitivity analysis to investigate the effects of the randomisation unit. </p> </section> <section id="CD010648-sec-0057"> <h5 class="title">Cross‐over trials</h5> <p>Cross‐over studies were not eligible for inclusion; this is not a suitable design for this type of intervention in labour. </p> </section> <section id="CD010648-sec-0058"> <h5 class="title">Other unit of analysis issues</h5> <p>If we had identified any trials with more than two arms (multi‐arm trials), we planned to include as many data as are relevant to the scope of the review. If such trials are identified when we update the review, where appropriate, we will combine arms (using the methods described in the <i>Handbook</i> (<a href="./references#CD010648-bbs2-0015" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>)) to create a single pair‐wise comparison. If it is not appropriate to combine experimental arms, we will present results separately for each arm, sharing results for the control arm between each to avoid double counting (for dichotomous outcomes we will divide the number of events and total sample by two; for continuous outcomes we will assume the same mean and standard deviation but halve the control sample size for each comparison). </p> </section> </section> <section id="CD010648-sec-0059"> <h4 class="title">Dealing with missing data</h4> <p>For included studies, we noted levels of attrition. We planned to explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis; in this version of the review we did not carry out any meta‐analysis and only two trials were included so we did not carry out this planned sensitivity analysis. </p> <p>For all outcomes, we carried out analyses, as far as possible, on an intention‐to‐treat basis, i.e. we attempted to include all participants randomised to each group in the analyses, and all participants were analysed in the group to which they were allocated, regardless of whether or not they received the allocated intervention. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing. </p> </section> <section id="CD010648-sec-0060"> <h4 class="title">Assessment of heterogeneity</h4> <p>If we had combined trials in the meta‐analysis, we planned to assess statistical heterogeneity using the T², I² and Chi² statistics. If we carry out meta‐analysis in updates, we will regard heterogeneity as substantial if an I² is greater than 30% and either the T² is greater than zero, or there is a low P value (less than 0.10) in the Chi² test for heterogeneity. </p> </section> <section id="CD010648-sec-0061"> <h4 class="title">Assessment of reporting biases</h4> <p>If in future updates there are 10 or more studies in the meta‐analysis, we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually. If asymmetry is suggested by a visual assessment, we will perform exploratory analyses to investigate it. </p> </section> <section id="CD010648-sec-0062"> <h4 class="title">Data synthesis</h4> <p>We carried out statistical analysis using Review Manager software (<a href="./references#CD010648-bbs2-0039" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>). If in future updates we carry out any meta‐analysis we will use fixed‐effect meta‐analysis for combining data where it is reasonable to assume that studies are estimating the same underlying treatment effect: i.e. where trials are examining the same intervention, and the trials’ populations and methods are judged to be sufficiently similar. If there is clinical heterogeneity sufficient to expect that the underlying treatment effects differ between trials, or if substantial statistical heterogeneity is detected, we will use random‐effects meta‐analysis to produce an overall summary where an average treatment effect across trials is considered clinically meaningful. The random‐effects summary will be treated as the average range of possible treatment effects, and we will discuss the clinical implications of treatment effects differing between trials. If the average treatment effect is not clinically meaningful, we will not combine trials. </p> <p>If we use random‐effects analyses, the results will be presented as the average treatment effect with 95% confidence intervals, and the estimates of T² and I². </p> </section> <section id="CD010648-sec-0063"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If in future updates we identify substantial heterogeneity, we will investigate it using subgroup analyses and sensitivity analyses. We will consider whether an overall summary is meaningful and, if it is, use random‐effects analysis to produce it. </p> <p>We plan to carry out the following subgroup analyses<b>:</b> </p> <p> <ul id="CD010648-list-0012"> <li> <p>by parity (primiparous versus multiparous);</p> </li> <li> <p>by dose (low‐dose versus higher‐dose titration);</p> </li> <li> <p>by whether titrated oral misoprostol is used as part of a labour induction regimen versus women in spontaneous labour. </p> </li> </ul> </p> <p>We will examine only our primary outcomes in subgroup analysis.</p> <p>We will assess subgroup differences by interaction tests available within RevMan (<a href="./references#CD010648-bbs2-0039" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>). We will report the results of subgroup analyses quoting the χ2 statistic and P value, and the interaction test I² value. </p> </section> <section id="CD010648-sec-0064"> <h4 class="title">Sensitivity analysis</h4> <p>If we had included cluster‐randomised trials in the review, we planned to carry out sensitivity analysis. We also planned sensitivity analysis according to trial quality; temporarily excluding trials at high risk of bias due to inadequate allocation concealment to explore whether this has any impact on the direction or size of the effect estimate. In this version of the review we did not carry out any sensitivity analysis as insufficient data were available and we did not carry out meta‐analysis. If more data are included in updates, we will carry out planned sensitivity analysis using our primary outcomes only. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010648-sec-0065" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010648-sec-0065"></div> <section id="CD010648-sec-0066"> <h3 class="title">Description of studies</h3> <section id="CD010648-sec-0067"> <h4 class="title">Results of the search</h4> <p>The search strategy identified four reports for possible inclusion in the review. We examined the reference lists of these four reports and did not identify any further studies for inclusion. After assessing eligibility, we included two trials and excluded one. One report was a trial registration for an ongoing study (<a href="./references#CD010648-bbs2-0004" title="Aalami‐HarandiR . Comparison the effect of oral misoprostol versus oxytocin on labor augmentation in pregnant women. Iranian Registry of Clinical Trials2009. ">Aalami‐Harandi 2009</a>) and we have contacted the authors for more information. Details of all trials identified by the search are set out in tables (<a href="./references#CD010648-sec-0125" title="">Characteristics of included studies</a>; <a href="./references#CD010648-sec-0126" title="">Characteristics of excluded studies</a>; <a href="./references#CD010648-sec-0127" title="">Characteristics of ongoing studies</a>). </p> </section> <section id="CD010648-sec-0068"> <h4 class="title">Included studies</h4> <p>Two trials examined oral misoprostol to augment labour.</p> <p>In a trial carried out in Taiwan between 2008 and 2009, 231 women were randomised to receive either titrated oral misoprostol or usual care (intravenous (IV) oxytocin) according to the hospital protocol (<a href="./references#CD010648-bbs2-0002" title="HoM , ChengSY , LiTC . Titrated oral misoprostol solution compared with intravenous oxytocin for labor augmentation: a randomized controlled trial. Obstetrics &amp; Gynecology2010;116(3):612‐8. ">Ho 2010</a>). Women recruited to the trial were in spontaneous labour with inadequate uterine contractions requiring augmentation. The misoprostol was prepared by dissolving a 200 microgram (mcg) tablet in tap water. Women in the misoprostol group were randomised to receive an initial dose of 20 mcg of misoprostol (in 20 mL of water) repeated every hour up to four hours, after which the dose was increased to 40 mcg per hour up to a maximum total dose of 1600 mcg. Women in both arms of the trial were monitored for signs of fetal distress or uterine hyperstimulation. All but three of the women randomised received the intended treatment. The primary outcomes in this study were duration of labour from the start of augmentation, vaginal delivery within 12 and 24 hours, incidence of tachysystole, uterine hyperstimulation, and non‐reassuring fetal heart rate. </p> <p>In the second trial, carried out in the USA between 2008 and 2011, 350 mainly Hispanic women were recruited (<a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a>). All women were in spontaneous labour with ruptured membranes requiring labour augmentation for slow progress. Women were randomised to receive either oral misoprostol or usual care (IV oxytocin). In this study the dose was not strictly titrated as in the <a href="./references#CD010648-bbs2-0002" title="HoM , ChengSY , LiTC . Titrated oral misoprostol solution compared with intravenous oxytocin for labor augmentation: a randomized controlled trial. Obstetrics &amp; Gynecology2010;116(3):612‐8. ">Ho 2010</a> trial, however, in view of the paucity of data on oral misoprostol for augmentation, we decided to include results from this trial in the review. In the <a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a> study, lower doses of misoprostol were achieved by cutting up 100 mcg tablets. Women were initially given 75 mcg of oral misoprostol which was repeated after four hours provided no adverse effects were observed. Primary outcomes in this trial were incidence of tachysystole, hypertonus, or both in a 10‐minute period, and women in both arms of the trial were closely monitored for signs of fetal distress or uterine hyperstimulation. There was considerable deviation from the protocol in this study although there was both intention‐to‐treat and as‐treated analyses for some outcomes (in the misoprostol group 136/176 (77.3%) received the study drug while in the control group 143/174 (82.2%) women received the control drug as intended). </p> </section> <section id="CD010648-sec-0069"> <h4 class="title">Excluded studies</h4> <p>One study identified by the search was excluded (<a href="./references#CD010648-bbs2-0003" title="PatelA , GilesJM , MoffettD , MahramR , DiroM , BurkettG . Can misoprostol be interchanged with oxytocin for augmentation of labor? [abstract]. Obstetrics &amp; Gynecology2000;95(4 Suppl):10S. ">Patel 2000</a>). The reason for exclusion was that in this trial IV oxytocin was compared with vaginal (rather than oral) misoprostol. </p> </section> </section> <section id="CD010648-sec-0070"> <h3 class="title">Risk of bias in included studies</h3> <p>Please see <a href="#CD010648-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD010648-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010648-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD010648-sec-0071"> <h4 class="title">Allocation</h4> <p>Both included studies were assessed as being at low risk of bias for random sequence generation and allocation concealment. Both studies used computer‐generated randomisation sequences and allocations were concealed in opaque envelopes. </p> </section> <section id="CD010648-sec-0072"> <h4 class="title">Blinding</h4> <p>Blinding of women, staff and outcome assessors was not attempted in either study and this may have introduced bias. The impact of lack of blinding on most of the outcomes measured was not clear. It is possible that lack of blinding may have led to changes in subsequent clinical assessments and decision‐making which may have affected some outcomes. </p> </section> <section id="CD010648-sec-0073"> <h4 class="title">Incomplete outcome data</h4> <p>One of the studies did not appear to have serious sample attrition (<a href="./references#CD010648-bbs2-0002" title="HoM , ChengSY , LiTC . Titrated oral misoprostol solution compared with intravenous oxytocin for labor augmentation: a randomized controlled trial. Obstetrics &amp; Gynecology2010;116(3):612‐8. ">Ho 2010</a>). In the study by <a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a>, there was some deviation from protocol which meant that results were more difficult to interpret: 20.30% of study participants overall (22.70% in experimental group and 17.80% in control group) did not receive study drugs and, while reasons were reported, the authors did not explain why the proportion attributable to progression to 8 cm prior to initiation of augmentation differed between groups (18/40 women in experimental group and 30/31 in control group). It was also unclear how many women randomised to the misoprostol arm eventually received oxytocin due to drug failure, as per study protocol. </p> </section> <section id="CD010648-sec-0074"> <h4 class="title">Selective reporting</h4> <p>Both studies were assessed as unclear for outcome reporting bias.</p> </section> <section id="CD010648-sec-0075"> <h4 class="title">Other potential sources of bias</h4> <p>Neither study had other obvious sources of bias. We have set out summaries of our 'Risk of bias' decisions in <a href="#CD010648-fig-0001">Figure 1</a>. </p> </section> </section> <section id="CD010648-sec-0076"> <h3 class="title" id="CD010648-sec-0076">Effects of interventions</h3> <section id="CD010648-sec-0077"> <h4 class="title">Titrated oral misoprostol versus intravenous oxytocin (2 studies with 581 women)</h4> <p>The studies in the review compared different regimens of titrated oral misoprostol with intravenous oxytocin. <a href="./references#CD010648-bbs2-0002" title="HoM , ChengSY , LiTC . Titrated oral misoprostol solution compared with intravenous oxytocin for labor augmentation: a randomized controlled trial. Obstetrics &amp; Gynecology2010;116(3):612‐8. ">Ho 2010</a> used 20 microgram (mcg) doses of misoprostol (repeated every hour up to four hours, after which the dose was increased to 40 mcg per hour up to a maximum total dose of 1600 mcg), while <a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a> gave women 75 mcg doses (repeated after four hours provided there were no adverse effects observed). </p> <p>As the two trials examined different interventions, we did not pool results in meta‐analyses.</p> <section id="CD010648-sec-0078"> <h5 class="title">Primary outcomes</h5> <section id="CD010648-sec-0079"> <h6 class="title">Maternal outcomes</h6> <section id="CD010648-sec-0080"> <p><b>Maternal death or severe morbidity (e.g. ruptured uterus, admission to intensive care unit, septicaemia, organ failure)</b></p> <p>This outcome was not reported in either of the included trials.</p> </section> <section id="CD010648-sec-0081"> <p><b>Uterine hyperstimulation with fetal heart rate (FHR) changes</b></p> <p>Both studies reported hyperstimulation with changes in FHR; neither trial showed clear differences between groups (<a href="./references#CD010648-bbs2-0002" title="HoM , ChengSY , LiTC . Titrated oral misoprostol solution compared with intravenous oxytocin for labor augmentation: a randomized controlled trial. Obstetrics &amp; Gynecology2010;116(3):612‐8. ">Ho 2010</a> (20 mcg dose): risk ratio (RR) 0.96, 95% confidence interval (CI) 0.14 to 6.68, 231 women, <a href="./references#CD010648-fig-0002" title="">Analysis 1.1</a>; <a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a> (75 mcg dose): RR 1.26, 95% CI 0.88 to1.80, 350 women <a href="./references#CD010648-fig-0017" title="">Analysis 2.1</a>). </p> <p>Overall, the rates of uterine hyperstimulation with FHR changes were very different in the two studies. A much higher proportion of women in the study carried out by <a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a> experienced hyperstimulation with FHR changes (29% of women receiving misoprostol and 23% of women receiving oxytocin) than those enrolled in <a href="./references#CD010648-bbs2-0002" title="HoM , ChengSY , LiTC . Titrated oral misoprostol solution compared with intravenous oxytocin for labor augmentation: a randomized controlled trial. Obstetrics &amp; Gynecology2010;116(3):612‐8. ">Ho 2010</a> (1.70% of women receiving misoprostol and 1.80% of women receiving oxytocin). These differences in background rates of hyperstimulation suggest that factors other than the dosing regimen differed between studies, such as the measurement of this outcome or other aspects of women's care. </p> </section> </section> <section id="CD010648-sec-0082"> <h6 class="title">Neonatal/fetal outcomes</h6> <section id="CD010648-sec-0083"> <p><b>Perinatal death (stillbirth and neonatal death)</b></p> <p>This outcome was not reported in either of the included trials.</p> </section> </section> </section> <section id="CD010648-sec-0084"> <h5 class="title">Secondary outcomes</h5> <section id="CD010648-sec-0085"> <h6 class="title">Maternal outcomes</h6> <section id="CD010648-sec-0086"> <p><b>Maternal mortality, or serious maternal morbidity (e.g. ruptured uterus, admission to intensive care unit, septicaemia, organ failure)</b></p> <p>These outcomes were not reported in either of the included trials.</p> </section> <section id="CD010648-sec-0087"> <p><b>Duration of labour</b></p> <p>This outcome was not reported in either of the included trials in a way that allowed us to enter data into data and analyses tables. <a href="./references#CD010648-bbs2-0002" title="HoM , ChengSY , LiTC . Titrated oral misoprostol solution compared with intravenous oxytocin for labor augmentation: a randomized controlled trial. Obstetrics &amp; Gynecology2010;116(3):612‐8. ">Ho 2010</a> reported the median and interquartile range (IQR) for the duration of labour from augmentation to vaginal delivery; the median time to delivery was 5.22 hours (IQR 3.77 to 8.58) in the misoprostol group compared with 5.20 hours (IQR 3.23 to 6.50) in the oxytocin group (P = 0.019) (data not shown). <a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a> reported no significant difference in the median time between start of augmentation and delivery (median 306 minutes, IQR 252 to 408 in the misoprostol group versus 276 minutes IQR 162 to 462 in the oxytocin group, P = 0.29 (data not shown)). </p> </section> <section id="CD010648-sec-0088"> <p><b>Caesarean section (CS)</b></p> <p>Both studies reported this outcome, and neither study showed any significant difference for rates of CS for women who had experienced augmentation with titrated oral misoprostol versus oxytocin (<a href="./references#CD010648-bbs2-0002" title="HoM , ChengSY , LiTC . Titrated oral misoprostol solution compared with intravenous oxytocin for labor augmentation: a randomized controlled trial. Obstetrics &amp; Gynecology2010;116(3):612‐8. ">Ho 2010</a> (20 mcg dose): RR 0.88, 95% CI 0.42 to 1.85, 231 women, <a href="./references#CD010648-fig-0003" title="">Analysis 1.3</a>; <a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a> (75 mcg dose): RR 1.04, 95% CI 0.57 to 1.92, 350 women, <a href="./references#CD010648-fig-0018" title="">Analysis 2.3</a>). <a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a> also provided data for CS for non‐reassuring FHR and prolonged labour; the difference between groups was not statistically significant for either indication (CS for fetal distress: RR 1.58, 95% CI 0.53 to 4.74, 350 women, <a href="./references#CD010648-fig-0020" title="">Analysis 2.6</a>; CS for prolonged labour: RR 0.84, 95% CI 0.39 to 1.82, 350 women, <a href="./references#CD010648-fig-0022" title="">Analysis 2.8</a>). </p> </section> <section id="CD010648-sec-0089"> <p><b>Instrumental birth</b></p> <p><a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a> reported the number of forceps deliveries in the two groups; overall, the number of events was low and the difference between groups was not significant (RR 1.98, 95% CI 0.37 to 10.66, 350 women, <a href="./references#CD010648-fig-0021" title="">Analysis 2.7</a>). </p> </section> <section id="CD010648-sec-0090"> <p><b>Duration of first and second stages of labour</b></p> <p>These outcomes were not reported in either of the included trials.</p> </section> <section id="CD010648-sec-0091"> <p><b>Postpartum haemorrhage (as defined by trialists)</b></p> <p>This outcome was not reported in either of the included trials.</p> </section> <section id="CD010648-sec-0092"> <p><b>Hyperstimulation of labour</b></p> <p>Results from the two studies regarding uterine hyperstimulation without FHR changes were measured in different ways, and findings were not consistent. Rates of tachysystole and hypertonus were reported by <a href="./references#CD010648-bbs2-0002" title="HoM , ChengSY , LiTC . Titrated oral misoprostol solution compared with intravenous oxytocin for labor augmentation: a randomized controlled trial. Obstetrics &amp; Gynecology2010;116(3):612‐8. ">Ho 2010</a>, who found a significantly lower incidence of tachysystole when labour was augmented with titrated oral misoprostol than with oxytocin (RR 0.39, 95% CI 0.17 to 0.91, 231 women, <a href="./references#CD010648-fig-0004" title="">Analysis 1.4</a>), and recorded no occurrences of hypertonus in either group of women (<a href="./references#CD010648-fig-0005" title="">Analysis 1.5</a>). On the other hand, <a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a> reported the incidence of uterine tachysystole, hypertonus, or both, in a 10‐minute period (hyperstimulation of labour) and more women whose labours had been augmented with titrated oral misoprostol experienced this outcome (RR 1.17, 95% CI 1.02 to 1.35, 350 women, <a href="./references#CD010648-fig-0023" title="">Analysis 2.9</a>). However, <a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a> also reported uterine tachysystole in a 20‐minute interval and for this outcome the difference between groups was not statistically significant (RR 1.21, 95% CI 0.84 to 1.72, 350 women, <a href="./references#CD010648-fig-0024" title="">Analysis 2.10</a>) </p> </section> <section id="CD010648-sec-0093"> <p><b>Diagnosis of chorioamnionitis</b></p> <p><a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a> reported the number of women with a diagnosis of chorioamnionitis; the difference between groups was not statistically significant (RR 0.87, 95% CI 0.55 to 1.37, 350 women, <a href="./references#CD010648-fig-0025" title="">Analysis 2.11</a>). </p> </section> <section id="CD010648-sec-0094"> <p><b>Other secondary outcomes</b></p> <p>Several of our secondary maternal outcomes were not reported in either trial (episiotomy, perineal trauma, breastfeeding, maternal satisfaction with care in labour, vaginal birth not achieved in 24 hours and postnatal depression). </p> <p><a href="./references#CD010648-bbs2-0002" title="HoM , ChengSY , LiTC . Titrated oral misoprostol solution compared with intravenous oxytocin for labor augmentation: a randomized controlled trial. Obstetrics &amp; Gynecology2010;116(3):612‐8. ">Ho 2010</a> reported vaginal delivery within 12 hours of commencement of augmentation (RR 0.91, 95% CI 0.80 to 1.03, 231 women, <a href="./references#CD010648-fig-0006" title="">Analysis 1.6</a>) and vaginal delivery within 24 hours of commencement of augmentation (RR 1.02, 95% CI 0.93 to 1.11, 231 women, <a href="./references#CD010648-fig-0007" title="">Analysis 1.7</a>). Neither of these outcomes showed a statistically significant difference between the two interventions. </p> </section> </section> <section id="CD010648-sec-0095"> <h6 class="title">Neonatal/Fetal outcomes</h6> <p>Most of our pre‐specified neonatal outcomes were not reported in either trial (fetal intrapartum death; early neonatal death; birth trauma (e.g. Erb's palsy, fractured skull, cephalhaematoma, fractured clavicle); neonatal morbidity, excluding malformations (e.g. seizures, birth asphyxia, neonatal encephalopathy, infection requiring antibiotics); need for intubation at birth; duration of infant hospital stay; or childhood disability). </p> <section id="CD010648-sec-0096"> <p><b>pH of arterial cord blood less than 7.0</b></p> <p><a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a> reported umbilical cord artery pH less than 7.1, however, the number of events was low in both groups, and the difference was not statistically significant (RR 0.74, 95% CI 0.17 to 3.26, data for 350 infants, <a href="./references#CD010648-fig-0026" title="">Analysis 2.12</a>). </p> </section> <section id="CD010648-sec-0097"> <p><b>Apgar score less than seven at five minutes</b></p> <p><a href="./references#CD010648-bbs2-0002" title="HoM , ChengSY , LiTC . Titrated oral misoprostol solution compared with intravenous oxytocin for labor augmentation: a randomized controlled trial. Obstetrics &amp; Gynecology2010;116(3):612‐8. ">Ho 2010</a> recorded no events for this outcome in either group (<a href="./references#CD010648-fig-0008" title="">Analysis 1.8</a>). </p> </section> <section id="CD010648-sec-0098"> <p><b>Admission to neonatal intensive care unit (NICU)</b></p> <p><a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a> and <a href="./references#CD010648-bbs2-0002" title="HoM , ChengSY , LiTC . Titrated oral misoprostol solution compared with intravenous oxytocin for labor augmentation: a randomized controlled trial. Obstetrics &amp; Gynecology2010;116(3):612‐8. ">Ho 2010</a> both reported admissions to NICU; the differences between groups were not statistically significant in either study (<a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a>: RR 2.97, 95% CI 0.12 to 72.31, data for 350 infants, <a href="./references#CD010648-fig-0027" title="">Analysis 2.13</a>; <a href="./references#CD010648-bbs2-0002" title="HoM , ChengSY , LiTC . Titrated oral misoprostol solution compared with intravenous oxytocin for labor augmentation: a randomized controlled trial. Obstetrics &amp; Gynecology2010;116(3):612‐8. ">Ho 2010</a>: RR 2.39, 95% CI 0.47 to 12.09, data for 231 infants, <a href="./references#CD010648-fig-0009" title="">Analysis 1.9</a>). Few babies were admitted to NICUs in these studies (seven out of 231 in <a href="./references#CD010648-bbs2-0002" title="HoM , ChengSY , LiTC . Titrated oral misoprostol solution compared with intravenous oxytocin for labor augmentation: a randomized controlled trial. Obstetrics &amp; Gynecology2010;116(3):612‐8. ">Ho 2010</a>, one out of 350 in <a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a>), so these studies did not have sufficient power to demonstrate differences for this outcome. </p> </section> </section> <section id="CD010648-sec-0099"> <h6 class="title">Non pre‐specified outcomes</h6> <section id="CD010648-sec-0100"> <p><b>Rate of failure to progress</b></p> <p><a href="./references#CD010648-bbs2-0002" title="HoM , ChengSY , LiTC . Titrated oral misoprostol solution compared with intravenous oxytocin for labor augmentation: a randomized controlled trial. Obstetrics &amp; Gynecology2010;116(3):612‐8. ">Ho 2010</a> reported failure to progress in labour; the difference between groups was not significant (RR 0.80, 95% CI 0.36 to 1.77, 231 women, <a href="./references#CD010648-fig-0010" title="">Analysis 1.10</a>). </p> </section> <section id="CD010648-sec-0101"> <p><b>Maternal side‐effects: nausea, vomiting, diarrhoea, shivering and pyrexia</b></p> <p><a href="./references#CD010648-bbs2-0002" title="HoM , ChengSY , LiTC . Titrated oral misoprostol solution compared with intravenous oxytocin for labor augmentation: a randomized controlled trial. Obstetrics &amp; Gynecology2010;116(3):612‐8. ">Ho 2010</a> reported data for several side‐effects commonly associated with augmentation of labour using misoprostol and/or oxytocin. The prevalence of these side‐effects was very low and there were no significant differences between groups in the number of women experiencing nausea, vomiting, shivering or pyrexia: nausea (RR 2.87 95% CI 0.12 to 69.82, 231 women, <a href="./references#CD010648-fig-0011" title="">Analysis 1.11</a>), vomiting (RR 2.87 95% CI 0.12 to 69.82, 231 women, <a href="./references#CD010648-fig-0012" title="">Analysis 1.12</a>), shivering (RR 2.87, 95% CI 0.12 to 69.82, 231 women, <a href="./references#CD010648-fig-0014" title="">Analysis 1.14</a>), and pyrexia (RR 2.87 95% CI 0.12 to 69.82, 231 women, <a href="./references#CD010648-fig-0015" title="">Analysis 1.15</a>). No experience of diarrhoea was reported (<a href="./references#CD010648-fig-0013" title="">Analysis 1.13</a>). The low number of events means that there was insufficient evidence to reach conclusions about the prevalence of side‐effects for misoprostol versus oxytocin. </p> </section> <section id="CD010648-sec-0102"> <p><b>Apgar score less than seven at one minute</b></p> <p><a href="./references#CD010648-bbs2-0002" title="HoM , ChengSY , LiTC . Titrated oral misoprostol solution compared with intravenous oxytocin for labor augmentation: a randomized controlled trial. Obstetrics &amp; Gynecology2010;116(3):612‐8. ">Ho 2010</a> reported on Apgar score less than seven at one minute; however, the number of events was very low and the difference between groups was not statistically significant (RR 4.79, 95% CI 0.23 to 98.69, data for 231 infants, <a href="./references#CD010648-fig-0016" title="">Analysis 1.17</a>). </p> </section> <section id="CD010648-sec-0103"> <p><b>Birthweight of newborn (g)</b></p> <p><a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a> provided data on birthweight. the difference between groups was not statistically significant (mean difference (MD) ‐22.00 g, 95% CI ‐117.96 to 73.96, data for 350 infants, <a href="./references#CD010648-fig-0031" title="">Analysis 2.17</a>). </p> </section> <section id="CD010648-sec-0104"> <p><b>Maternal blood transfusion for hypovolaemia</b></p> <p><a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a> reported the number of women requiring blood transfusions for hypovolaemia; however, the number of events was low, and the difference between groups was not significant (RR 2.97, 95% CI 0.61 to 14.49, 350 women, <a href="./references#CD010648-fig-0019" title="">Analysis 2.5</a>). </p> </section> <section id="CD010648-sec-0105"> <p><b>Apgar score less than four at five minutes</b></p> <p>No babies born to women recruited by <a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a> had an Apgar score less than at five minutes (<a href="./references#CD010648-fig-0028" title="">Analysis 2.14</a>). </p> </section> <section id="CD010648-sec-0106"> <p><b>Spontaneous vaginal delivery</b></p> <p><a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a> showed no clear differences in the rate of spontaneous vaginal delivery between women who received titrated oral misoprostol versus oxytocin (RR 0.98, 95% CI 0.91 to 1.06, 350 women, <a href="./references#CD010648-fig-0029" title="">Analysis 2.15</a>). </p> </section> <section id="CD010648-sec-0107"> <p><b>Epidural analgesia</b></p> <p><a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a> reported on use of epidural analgesia. There was a trend towards lower use of epidural analgesia among women with labours augmented using misoprostol, although this difference did not reach statistical significance (RR 0.92, 95% CI 0.84 to 1.01, 350 women, <a href="./references#CD010648-fig-0030" title="">Analysis 2.16</a>) </p> </section> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010648-sec-0108" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010648-sec-0108"></div> <section id="CD010648-sec-0109"> <h3 class="title" id="CD010648-sec-0109">Summary of main results</h3> <p>The two trials included in this review used different oral misoprostol regimens to augment labour, complicating comparisons of outcomes. Neither trial reported maternal death, severe maternal morbidity, or fetal/neonatal mortality outcomes, and only a few fetal/neonatal morbidity outcomes were considered, none of which were significantly different between groups. For several outcomes (such as maternal side‐effects, instrumental birth, maternal blood transfusion for hypovolaemia and epidural analgesia), the number of events was generally too low for sufficient statistical power to be achieved, and maternal satisfaction was not used as an outcome in either trial. The duration of labour from the start of augmentation to delivery in the <a href="./references#CD010648-bbs2-0002" title="HoM , ChengSY , LiTC . Titrated oral misoprostol solution compared with intravenous oxytocin for labor augmentation: a randomized controlled trial. Obstetrics &amp; Gynecology2010;116(3):612‐8. ">Ho 2010</a> trial was slightly less in the oxytocin group compared with the misoprostol group (median 5.20 hours compared with 5.22). <a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a> reported no significant difference between groups in the interval between start of augmentation and delivery. Neither trial had significantly higher rates of uterine hyperstimulation with fetal heart rate (FHR) changes in the titrated oral misoprostol group. However, the rates of this outcome varied so greatly between the two studies to suggest that other factors were at play. </p> <p>Neither trial reported significantly higher rates of CS in the oral misoprostol group, nor CS for non‐reassuring FHR or prolonged labour in the trial using a 75 mcg misoprostol dose (<a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a>). Rates of vaginal delivery within 12 and 24 hours of commencing augmentation were not significantly different in the trial using a 20 mcg misoprostol dose (<a href="./references#CD010648-bbs2-0002" title="HoM , ChengSY , LiTC . Titrated oral misoprostol solution compared with intravenous oxytocin for labor augmentation: a randomized controlled trial. Obstetrics &amp; Gynecology2010;116(3):612‐8. ">Ho 2010</a>). The only significant differences in these two trials related to hyperstimulation and the results from the trials were not consistent. Following titrated oral misoprostol in the <a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a> trial, significantly more women experienced hyperstimulation of labour (tachysystole, hypertonus or both) in a 10‐minute interval compared to those receiving oxytocin. However, we find it noteworthy that <a href="./references#CD010648-bbs2-0002" title="HoM , ChengSY , LiTC . Titrated oral misoprostol solution compared with intravenous oxytocin for labor augmentation: a randomized controlled trial. Obstetrics &amp; Gynecology2010;116(3):612‐8. ">Ho 2010</a> reported a significantly lower incidence of tachysystole when labour was augmented with titrated oral misoprostol compared to oxytocin (via an electronic infusion pump), and recorded no occurrences of hypertonus in either group. This suggests that lower doses of misoprostol for augmentation are a credible alternative to an uncontrolled oxytocin infusion in order to avoid hyperstimulation. </p> </section> <section id="CD010648-sec-0110"> <h3 class="title" id="CD010648-sec-0110">Overall completeness and applicability of evidence</h3> <p>Titrated oral misoprostol use was not associated with lower rates of vaginal delivery or higher rates of CS compared to intravenous (IV) oxytocin regimens in women with dystocia following spontaneous onset of labour. The association between misoprostol use and uterine hyperstimulation (<a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a>) is not a new finding; however, the higher oral misoprostol dose (75 mcg) used in the <a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a> trial (compared with the 20 mcg dose in <a href="./references#CD010648-bbs2-0002" title="HoM , ChengSY , LiTC . Titrated oral misoprostol solution compared with intravenous oxytocin for labor augmentation: a randomized controlled trial. Obstetrics &amp; Gynecology2010;116(3):612‐8. ">Ho 2010</a>) may have been a contributing factor. We did not identify any trials examining other comparisons (such as oral misoprostol against placebo or other augmentation methods), nor did we identify trials examining differences in outcomes following induction, rather than in women who labour spontaneously. </p> </section> <section id="CD010648-sec-0111"> <h3 class="title" id="CD010648-sec-0111">Quality of the evidence</h3> <p>Both of the trials included in the review were of fairly good methodological quality. Both trials used methods of randomisation which we assessed as low risk of bias, and overall rates of sample attrition were low. Blinding women, staff and outcome assessors for these types of interventions is not simple as both groups would have needed either placebo IV infusions or oral drugs; the impact of lack of blinding on outcomes is uncertain. The results of the <a href="./references#CD010648-bbs2-0001" title="BleichAT , VillanoKS , LoJY , AlexanderJM , McIntireDD , LevenoKJ . Oral misoprostol for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology2011;118(6):1255‐60. ">Bleich 2011</a> study were more difficult to interpret because women in both groups did not receive the intended treatment, and the reasons for this did not appear to be the same in the two arms of the trial; on the other hand, both an intention‐to‐treat and as‐treated analyses were presented for selected outcomes. </p> </section> <section id="CD010648-sec-0112"> <h3 class="title" id="CD010648-sec-0112">Potential biases in the review process</h3> <p>We are aware that the review process itself may be subject to bias, and we attempted to minimise this in a number of ways. Assessment of eligibility and data extraction were carried out independently by two review authors (J Vogel and H West). Assessment of risk of bias was also carried out independently by two review authors and a consensus reached through discussion; we have provided detailed information in <a href="./references#CD010648-sec-0125" title="">Characteristics of included studies</a><i>Risk of Bias</i> tables to explain our decisions, but it is possible a different review team may have made slightly different assessments. </p> </section> <section id="CD010648-sec-0113"> <h3 class="title" id="CD010648-sec-0113">Agreements and disagreements with other studies or reviews</h3> <p>There are no other reviews of titrated oral misoprostol regimens for augmentation. However, a Cochrane review (<a href="./references#CD010648-bbs2-0006" title="AlfirevicZ , WeeksA . Oral misoprostol for induction of labour. Cochrane Database of Systematic Reviews2006, Issue 2. [DOI: 10.1002/14651858.CD001338.pub2] ">Alfirevic 2006</a>) of oral misoprostol for induction of labour contained a subgroup analysis of oral misoprostol versus IV oxytocin for induction. In the eight trials including 1026 women for this comparison, the only overall difference in outcomes was an increase in meconium‐stained liquor in women with ruptured membranes in the oral misoprostol group. There was not a significant difference in hyperstimulation of labour outcomes (with or without FHR changes). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010648-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010648-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/full#CD010648-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 1 Uterine hyperstimulation with non‐reassuring heart rate changes." data-id="CD010648-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 1 Uterine hyperstimulation with non‐reassuring heart rate changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 3 Caesarean section." data-id="CD010648-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 4 Incidence of tachysystole." data-id="CD010648-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 4 Incidence of tachysystole. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 5 Incidence of hypertonus." data-id="CD010648-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 5 Incidence of hypertonus. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 6 Vaginal delivery within 12 hours of commencement of augmentation." data-id="CD010648-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 6 Vaginal delivery within 12 hours of commencement of augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 7 Vaginal delivery within 24 hours of commencement of augmentation." data-id="CD010648-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 7 Vaginal delivery within 24 hours of commencement of augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 8 Apgar &lt; 7 at 5 minutes." data-id="CD010648-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 8 Apgar &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 9 Admission to neonatal intensive care unit (NICU)." data-id="CD010648-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 9 Admission to neonatal intensive care unit (NICU). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 10 Non pre‐specified outcome: Rate of failure to progress." data-id="CD010648-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 10 Non pre‐specified outcome: Rate of failure to progress. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 11 Non pre‐specified outcome: Maternal side‐effects: nausea." data-id="CD010648-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 11 Non pre‐specified outcome: Maternal side‐effects: nausea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 12 Non pre‐specified outcome: Maternal side‐effects: vomiting." data-id="CD010648-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 12 Non pre‐specified outcome: Maternal side‐effects: vomiting. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 13 Non pre‐specified outcome: Maternal side‐effects: diarrhoea." data-id="CD010648-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 13 Non pre‐specified outcome: Maternal side‐effects: diarrhoea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 14 Non pre‐specified outcome: Maternal side‐effects: shivering." data-id="CD010648-fig-0014" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 14 Non pre‐specified outcome: Maternal side‐effects: shivering. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 15 Non pre‐specified outcome: Maternal side‐effects: pyrexia." data-id="CD010648-fig-0015" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 15 Non pre‐specified outcome: Maternal side‐effects: pyrexia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 17 Non pre‐specified outcome: Apgar score &lt; 7 at 1 minute." data-id="CD010648-fig-0016" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Titrated misoprostol (20 mcg dose) vs intravenous oxytocin, Outcome 17 Non pre‐specified outcome: Apgar score &lt; 7 at 1 minute. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 1 Uterine hyperstimulation (tachysystole, hypertonus or both) associated with fetal heart changes." data-id="CD010648-fig-0017" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 1 Uterine hyperstimulation (tachysystole, hypertonus or both) associated with fetal heart changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 3 Caesarean section." data-id="CD010648-fig-0018" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 5 Maternal blood transfusion for hypovolemia." data-id="CD010648-fig-0019" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 5 Maternal blood transfusion for hypovolemia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 6 Caesarean for non‐reassuring fetal heart rate (i.e. fetal distress)." data-id="CD010648-fig-0020" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 6 Caesarean for non‐reassuring fetal heart rate (i.e. fetal distress). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 7 Forceps delivery." data-id="CD010648-fig-0021" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 7 Forceps delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 8 Caesarean section for dystocia (i.e. prolonged labour)." data-id="CD010648-fig-0022" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 8 Caesarean section for dystocia (i.e. prolonged labour). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-002-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-002-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 9 Uterine tachysystole, hypertonus, or both in 10‐minute period (hyperstimulation of labour)." data-id="CD010648-fig-0023" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 9 Uterine tachysystole, hypertonus, or both in 10‐minute period (hyperstimulation of labour). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-002-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-002-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 10 Uterine tachysystole in a 20‐minute interval." data-id="CD010648-fig-0024" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 10 Uterine tachysystole in a 20‐minute interval. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-002-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-002-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 11 Chorioamnionitis." data-id="CD010648-fig-0025" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 11 Chorioamnionitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-002-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-002-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 12 Umbilical cord artery pH &lt; 7.1." data-id="CD010648-fig-0026" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.12</div> <div class="figure-caption"> <p>Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 12 Umbilical cord artery pH &lt; 7.1. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-002-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-002-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 13 Admission to neonatal intensive care unit (NICU)." data-id="CD010648-fig-0027" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.13</div> <div class="figure-caption"> <p>Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 13 Admission to neonatal intensive care unit (NICU). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-002-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-002-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 14 Non pre‐specified outcome: Apgar score &lt; 4 at 5 minutes." data-id="CD010648-fig-0028" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.14</div> <div class="figure-caption"> <p>Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 14 Non pre‐specified outcome: Apgar score &lt; 4 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-002-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-002-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 15 Non pre‐specified outcome: Spontaneous vaginal delivery." data-id="CD010648-fig-0029" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.15</div> <div class="figure-caption"> <p>Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 15 Non pre‐specified outcome: Spontaneous vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-002-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-002-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 16 Non pre‐specified outcome: Epidural analgesia." data-id="CD010648-fig-0030" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.16</div> <div class="figure-caption"> <p>Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 16 Non pre‐specified outcome: Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010648-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/urn:x-wiley:14651858:media:CD010648:CD010648-CMP-002-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_t/tCD010648-CMP-002-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 17 Non pre‐specified outcome: Birthweight." data-id="CD010648-fig-0031" src="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.17</div> <div class="figure-caption"> <p>Comparison 2 Titrated misoprostol (75 mcg dose) vs intravenous oxytocin, Outcome 17 Non pre‐specified outcome: Birthweight. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/media/CDSR/CD010648/image_n/nCD010648-CMP-002-17.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="comparison" data-id="CD010648-tbl-0001"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Titrated misoprostol (20 mcg dose) vs intravenous oxytocin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Uterine hyperstimulation with non‐reassuring heart rate changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.14, 6.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2 Duration of labour (e.g.: 3 cm dilatation to delivery), in minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.42, 1.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Incidence of tachysystole <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.17, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Incidence of hypertonus <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Vaginal delivery within 12 hours of commencement of augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.80, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Vaginal delivery within 24 hours of commencement of augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.93, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Apgar &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Admission to neonatal intensive care unit (NICU) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.39 [0.47, 12.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Non pre‐specified outcome: Rate of failure to progress <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.36, 1.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Non pre‐specified outcome: Maternal side‐effects: nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.87 [0.12, 69.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Non pre‐specified outcome: Maternal side‐effects: vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.87 [0.12, 69.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Non pre‐specified outcome: Maternal side‐effects: diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Non pre‐specified outcome: Maternal side‐effects: shivering <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.87 [0.12, 69.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Non pre‐specified outcome: Maternal side‐effects: pyrexia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.87 [0.12, 69.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16 Non pre‐specified outcome: Total dosage of oxytocin or misoprostol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Non pre‐specified outcome: Apgar score &lt; 7 at 1 minute <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.79 [0.23, 98.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18 Non pre‐specified outcome: Active phase interval</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19 Non pre‐specified outcome: Birthweight of newborn</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Titrated misoprostol (20 mcg dose) vs intravenous oxytocin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010648-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Titrated misoprostol (75 mcg dose) vs intravenous oxytocin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Uterine hyperstimulation (tachysystole, hypertonus or both) associated with fetal heart changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.88, 1.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2 Duration of labour (from start of augmentation to delivery), in minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.57, 1.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4 Duration of second stage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Maternal blood transfusion for hypovolemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.97 [0.61, 14.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Caesarean for non‐reassuring fetal heart rate (i.e. fetal distress) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.58 [0.53, 4.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Forceps delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.98 [0.37, 10.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Caesarean section for dystocia (i.e. prolonged labour) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.39, 1.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Uterine tachysystole, hypertonus, or both in 10‐minute period (hyperstimulation of labour) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [1.02, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Uterine tachysystole in a 20‐minute interval <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.84, 1.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Chorioamnionitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.55, 1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Umbilical cord artery pH &lt; 7.1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.17, 3.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Admission to neonatal intensive care unit (NICU) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.97 [0.12, 72.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Non pre‐specified outcome: Apgar score &lt; 4 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Non pre‐specified outcome: Spontaneous vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.91, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Non pre‐specified outcome: Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.84, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Non pre‐specified outcome: Birthweight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐22.0 [‐117.96, 73.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18 Non pre‐specified outcome: Maximum number of Monteovideo units</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19 Non pre‐specified outcome: Maximum oxytocin dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20 Non pre‐specified outcome: Admission to study drug (minutes)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Titrated misoprostol (75 mcg dose) vs intravenous oxytocin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010648.pub2/references#CD010648-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010648.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010648-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fr#CD010648-note-0001">Français</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD010648-note-0006">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br/> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010648\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010648\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010648\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010648\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010648\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010648\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010648\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010648\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010648\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010648\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010648\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010648\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010648\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010648\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010648\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010648\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010648\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010648\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=QO4KtYGW&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010648.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010648.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010648.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010648.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010648.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740728176617"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010648.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740728176621"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010648.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ebe16bdd7f498',t:'MTc0MDcyODE3Ni4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 